Evidence map›Paper›PMID 32655475›Full record

ArticleFrontiers in neurology2020

Brain Proteomic Profiling in Intractable Epilepsy Caused by TSC1 Truncating Mutations: A Small Sample Study.

Yi-Dan Liu, Meng-Yu Ma, Xi-Bin Hu, Huan Yan, Yan-Ke Zhang, Hao-Xiang Yang, Jing-Hui Feng, Lin Wang, Hao Zhang, Bin Zhang and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Eukaryotic translation initiation factorExperimental and therapeutic medicine · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Neuroproteomics in Epilepsy: What Do We Know so Far?Frontiers in molecular neuroscience · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Yi-Dan LiuCheeloo College of Medicine, Shandong University, Jinan, China.
Meng-Yu MaCheeloo College of Medicine, Shandong University, Jinan, China.
Xi-Bin HuDepartment of Imaging, Affiliated Hospital of Jining Medical University, Jining, China.
Huan YanDepartment of Neurology, Affiliated Hospital of Jining Medical University, Jining, China.
Yan-Ke ZhangDepartment of Neurology, Affiliated Hospital of Jining Medical University, Jining, China.
Hao-Xiang YangClinical Medical College, Jining Medical University, Jining, China.
Jing-Hui FengClinical Medical College, Jining Medical University, Jining, China.
Lin WangDepartment of Neurology, Affiliated Hospital of Jining Medical University, Jining, China.
Hao ZhangDepartment of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining, China.
Bin ZhangDepartment of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining, China.
Qiu-Bo LiDepartment of Pediatrics, Affiliated Hospital of Jining Medical University, Jining, China.
Jun-Chen ZhangDepartment of Neurosurgery, Affiliated Hospital of Jining Medical University, Jining, China.
Qing-Xia KongDepartment of Neurology, Affiliated Hospital of Jining Medical University, Jining, China.
Affiliated Hospital of Jining Medical University · CNJining Medical University · CNShandong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Tuberous sclerosis complex (TSC) is a genetic disease characterized by seizures, mental deficiency, and abnormalities of the skin, brain, kidney, heart, and lungs. TSC is inherited in an autosomal dominant manner and is caused by variations in either the TSC1 or TSC2 gene. TSC-related epilepsy (TRE) is the most prevalent and challenging clinical feature of TSC, and more than half of the patients have refractory epilepsy. In clinical practice, we found several patients of intractable epilepsy caused by TSC1 truncating mutations. To study the changes of protein expression in the brain, three cases of diseased brain tissue with TSC1 truncating mutation resected in intractable epilepsy operations and three cases of control brain tissue resected in craniocerebral trauma operations were collected to perform protein spectrum detection, and then the data-independent acquisition (DIA) workflow was used to analyze differentially expressed proteins. As a result, there were 55 up- and 55 down-regulated proteins found in the damaged brain tissue with TSC1 mutation compared to the control. Further bioinformatics analysis revealed that the differentially expressed proteins were mainly concentrated in the synaptic membrane between the patients with TSC and the control. Additionally, TSC1 truncating mutations may affect the pathway of amino acid metabolism. Our study provides a new idea to explore the brain damage mechanism caused by TSC1 mutations.

Indexed as

epilepsymutationproteomic profilingTSC1 genetuberous sclerosis complex

Identifiers

PMID32655475
PMCPMC7326032
OpenAlexW3030183997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.